Enzyme function modification method and enzyme variant thereof

Patent metadata

Field	Value
Publication number	US-9416350-B2
Application number	US-201214129834-A
Country	US
Kind code	B2
Filing date	Jun 27, 2012
Priority date	Jun 28, 2011
Publication date	Aug 16, 2016
Grant date	Aug 16, 2016

Abstract

An object of the present invention is to provide a method for converting the coenzyme dependency of enzymes of the medium-chain dehydrogenase/reductase (MDR) family. A further object of the present invention is to provide enzyme variants of the MDR family whose coenzyme dependency is converted by the conversion method and a method for enzymatically producing optically active alcohols using the enzymes. The present inventors developed a novel enzyme conversion method for converting the coenzyme dependency of enzymes of the MDR family, rationally designed enzyme variants that are altered by the enzyme conversion method to be able to use NADPH as a coenzyme from a useful enzyme of the MDR family that uses NADH as a coenzyme, and actually provide variants having such an ability.

First claim

The invention claimed is:

1. A protein of medium-chain dehydrogenase/reductase family, containing at least one of following amino acid residues (a) to (d):
(a) Ala at a position conformationally equivalent to Asp-201 of SEQ ID NO: 1;
(b) Arg at a position conformationally equivalent to Lys-202 of SEQ ID NO: 1;
(c) Ser at a position conformationally equivalent to Lys-203 of SEQ ID NO: 1; or
(d) Lys at a position conformationally equivalent to Ala-206 of SEQ ID NO: 1.

2. The protein according to claim 1 , wherein the protein comprises an amino acid sequence having at least 85% sequence identity to the amino acid sequence of SEQ ID NO: 1.

3. The protein according to claim 1 or 2 , wherein the protein comprises an amino acid sequence obtained by introducing at least one of the following mutations (e) to (h) into the amino acid sequence of SEQ ID NO: 1:
(e) a substitution of Ala for Asp-201;
(f) a substitution of Arg for Lys-202;
(g) a substitution of Ser for Lys-203; or
(h) a substitution of Lys for Ala-206.

4. The protein according to claim 1 , Wherein the protein comprises any one of amino acid sequences of SEQ ID NOs: 2 to 8.

5. A DNA, comprising a base sequence encoding a protein of medium-chain dehydrogenase/reductase family, containing at least one of following amino acid residues (a) to (d):
(a) Ala at a position conformationally equivalent to Asp-201 of SEQ ID NO: 1;
(b) Arg at a position conformationally equivalent to Lys-202 of SEQ ID NO: 1;
(c) Ser at a position conformationally equivalent to Lys-203 of SEQ ID NO: 1; or
(d) Lys at a position conformationally equivalent to Ala-206 of SEQ ID NO: 1.

6. A DNA, selected from the group consisting of:
(A) a DNA comprising any one of base sequences of SEQ ID NOs: 25 to 31;
(B) a DNA which is capable of hybridizing with a DNA comprising a base sequence complementary to any one of base sequences of SEQ ID NOs: 25 to 31 under stringent conditions, and comprises a base sequence encoding a protein having oxidoreductase activity, Wherein the stringent conditions are hybridization using a filter with a colony- or plaque-derived DNA immobilized thereon in the presence of 0.7 to 1.0 M NaCl at 65° C., and washing the filter at 65° C. with a 2×SSC solution, with the proviso that a DNA of SEQ ID NO: 9 is excluded; and
(C) a DNA having at least 85% sequence identity to any one of base sequences of SEQ ID NOs: 25 to 31, and comprising a base sequence encoding a protein having oxidoreductase activity, with the proviso that a DNA of SEQ ID NO: 9 is excluded.

7. A vector, comprising the DNA according claim 5 or 6 .

8. A transformant, obtained by transformation of a host cell with the vector according to claim 7 .

9. A culture of the transformant according to claim 8 .

10. A method for producing oxidized nicotinamide adenine dinucleotide phosphate, the method comprising allowing the protein according to claim 1 to react with and to convert reduced nicotinamide adenine dinucleotide phosphate into oxidized nicotinamide adenine dinucleotide phosphate.

11. A method for producing reduced nicotinamide adenine dinucleotide phosphate, the method comprising:
providing the protein according to claim 1 to react with and to convert oxidized nicotinamide adenine dinucleotide phosphate into reduced nicotinamide adenine dinucleotide phosphate.

12. A method for producing reduced nicotinamide adenine dinucleotide phosphate, the method comprising allowing a reductase to act on the oxidized nicotinamide adenine dinucleotide phosphate obtained by the method according to claim 10 .

13. A method for producing oxidized nicotinamide adenine dinucleotide phosphate, the method comprising allowing an oxidase to act on the reduced nicotinamide adenine dinucleotide phosphate obtained by the method according to claim 11 .

14. The production method according claim 10 , which further comprises using a transformant obtained by transformation of a host cell with a vector comprising a DNA encoding the protein of claim 1 .

15. The production method according to claim 10 , which comprises using a transformant obtained by transformation of a host cell with a vector encoding said protein with the further proviso that the protein is encoded by a DNA selected from the group consisting of:
(A) a DNA comprising any one of base sequences of SEQ ID NOs: 25 to 31;
(B) a DNA which is capable of hybridizing with a DNA comprising a base sequence complementary to any one of base sequences of SEQ ID NOs: 25 to 31 under stringent conditions, and comprises a base sequence encoding a protein having oxidoreductase activity, wherein the stringent conditions are hybridization using a filter with a colony- or plaque-derived DNA immobilized thereon in the presence of 0.7 to 1.0 M NaCl at 65° C., and washing the filter at 65° C. with a 2×SSC solution; and
(C) a DNA having at least 85% sequence identity to any one of base sequences of SEQ ID NOs: 25 to 31, and comprising a base sequence encoding a protein having oxidoreductase activity,
wherein (A), (B), and (C) encode the protein of medium-chain dehydrogenase/reductase family containing at least one of following amino acid residues (a) to (d):
(a) Ala at a position conformationally equivalent to Asp-201 of SEQ ID NO: 1;
(b) Arg at a position conformationally equivalent to Lys-202 of SEQ ID NO: 1;
(c) Ser at a position conformationally equivalent to Lys-203 of SEQ ID NO: 1; or
(d) Lys at a position conformationally equivalent to Ala-206 of SEQ ID NO: 1.

16. The protein according to claim 1 , wherein the protein comprises:
(a) Ala at a position conformationally equivalent to Asp-201 of SEQ ID NO: 1.

17. The protein according to claim 1 , wherein the protein comprises:
(b) Arg at a position conformationally equivalent to Lys-202 of SEQ ID NO: 1.

18. The protein according to claim 1 , wherein the protein comprises:
(c) Ser at a position conformationally equivalent to Lys-203 of SEQ ID NO: 1.

19. The protein according to claim 1 , wherein the protein comprises:
(d) Lys at a position conformationally equivalent to Ala-206 of SEQ ID NO: 1.

20. The protein according to claim 1 , wherein the protein comprises SEQ ID NO:1 except that it contains two of the following amino acid substitutions at amino acid positions 201, 202, 203, and 206 of SEQ ID NO 1:
(a) Ala at a position conformationally equivalent to Asp-201 of SEQ ID NO: 1;
(b) Arg at a position conformationally equivalent to Lys-202 of SEQ ID NO: 1;
(c) Ser at a position conformationally equivalent to Lys-203 of SEQ ID NO: 1; or
(d) Lys at a position conformationally equivalent to Ala-206 of SEQ ID NO: 1.

21. The protein according to claim 1 , wherein the protein comprises SEQ ID No:1 except that it contains three of the following amino acid substitutions at amino acid positions 201, 202, 203, and 206 of SEQ ID NO 1:
(a) Ala at a position conformationally equivalent to Asp-201 of SEQ ID NO: 1;
(b) Arg at a position conformationally equivalent to Lys-202 of SEQ ID NO: 1;
(c) Ser at a position conformationally equivalent to Lys-203 of SEQ ID NO: 1; or
(d) Lys at a position conformationally equivalent to Ala-206 of SEQ ID NO: 1.

22. The protein according to claim 1 , wherein the protein comprises SEQ ID NO:1 except that it contains four of the following amino acid substitutions at amino acid positions 201, 202, 203, and 206 of SEQ ID NO 1:
(a) Ala at a position conformationally equivalent to Asp-201 of SEQ ID NO: 1;
(b) Arg at a position conforma

Assignees

• Yoshida Shinichi
• Taira Shunichi
• Nishihachijyo Masakatsu
• Nojiri Masutoshi
• Kawano Shigeru
• Kaneka Corp

Inventors

• Yoshida Shinichi
• Taira Shunichi
• Nishihachijyo Masakatsu
• Nojiri Masutoshi
• Kawano Shigeru

Classifications

• C12N9/0006 Primary

  acting on CH-OH groups as donors (1.1) · CPC title

• C07H19/207

  the phosphoric or polyphosphoric acids being esterified by a further hydroxylic compound, e.g. flavine adenine dinucleotide or nicotinamide-adenine dinucleotide · CPC title

• C12P19/36

  Dinucleotides, e.g. nicotineamide-adenine dinucleotide phosphate · CPC title

• Y02P20/52

  using catalysts, e.g. selective catalysts · CPC title